India
· Delayed Price · Currency is INR Divi's Laboratories Statistics
Total Valuation
Divi's Laboratories has a market cap or net worth of INR 1.55 trillion. The enterprise value is 1.52 trillion.
| Market Cap | 1.55T |
| Enterprise Value | 1.52T |
Important Dates
The next estimated earnings date is Friday, January 31, 2025.
| Earnings Date | Jan 31, 2025 |
| Ex-Dividend Date | Aug 2, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 122.26M |
Valuation Ratios
The trailing PE ratio is 84.54.
| PE Ratio | 84.54 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 11.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 59.18, with an EV/FCF ratio of 319.20.
| EV / Earnings | 82.58 |
| EV / Sales | 17.60 |
| EV / EBITDA | 59.18 |
| EV / EBIT | 69.58 |
| EV / FCF | 319.20 |
Financial Position
The company has a current ratio of 7.24, with a Debt / Equity ratio of 0.00.
| Current Ratio | 7.24 |
| Quick Ratio | 4.48 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.02 |
| Interest Coverage | 726.33 |
Financial Efficiency
Return on equity (ROE) is 13.91% and return on invested capital (ROIC) is 10.31%.
| Return on Equity (ROE) | 13.91% |
| Return on Assets (ROA) | 9.12% |
| Return on Capital (ROIC) | 10.31% |
| Revenue Per Employee | 8.84M |
| Profits Per Employee | 1.88M |
| Employee Count | 9,741 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 1.20 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +56.94% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +56.94% |
| 50-Day Moving Average | 5,948.69 |
| 200-Day Moving Average | 4,814.48 |
| Relative Strength Index (RSI) | 43.53 |
| Average Volume (20 Days) | 15,384 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Divi's Laboratories had revenue of INR 86.14 billion and earned 18.36 billion in profits. Earnings per share was 69.15.
| Revenue | 86.14B |
| Gross Profit | 49.38B |
| Operating Income | 21.79B |
| Pretax Income | 25.28B |
| Net Income | 18.36B |
| EBITDA | 25.61B |
| EBIT | 21.79B |
| Earnings Per Share (EPS) | 69.15 |
Balance Sheet
The company has 36.02 billion in cash and 80.00 million in debt, giving a net cash position of 35.94 billion.
| Cash & Cash Equivalents | 36.02B |
| Total Debt | 80.00M |
| Net Cash | 35.94B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 137.17B |
| Book Value Per Share | 516.40 |
| Working Capital | 80.50B |
Cash Flow
In the last 12 months, operating cash flow was 16.48 billion and capital expenditures -11.73 billion, giving a free cash flow of 4.75 billion.
| Operating Cash Flow | 16.48B |
| Capital Expenditures | -11.73B |
| Free Cash Flow | 4.75B |
| FCF Per Share | n/a |
Margins
Gross margin is 57.33%, with operating and profit margins of 25.30% and 21.31%.
| Gross Margin | 57.33% |
| Operating Margin | 25.30% |
| Pretax Margin | 29.35% |
| Profit Margin | 21.31% |
| EBITDA Margin | 29.73% |
| EBIT Margin | 25.30% |
| FCF Margin | 5.51% |
Dividends & Yields
Divi's Laboratories does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 43.36% |
| Buyback Yield | -0.03% |
| Shareholder Yield | -0.03% |
| Earnings Yield | 1.18% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on September 23, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Sep 23, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |